Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II)

dc.contributor.author	Brecht, Ines B.
dc.date.accessioned	2026-09-28T08:55:27Z
dc.date.available	2026-09-28T08:55:27Z
dc.date.issued	2026
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/183834
dc.language.iso	en	de_DE
dc.publisher	Philadelphia : Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO-25-01447	de_DE
dc.subject.ddc	610	de_DE
dc.title	Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20260422000000_00224
utue.publikation.seiten	849-860	de_DE
utue.personen.roh	Hernaiz Driever, Pablo
utue.personen.roh	Kordes, Uwe R.
utue.personen.roh	Brecht, Ines B.
utue.personen.roh	Saletti, Veronica
utue.personen.roh	Fisher, Michael J.
utue.personen.roh	Doughton, Gail
utue.personen.roh	Arefayene, Million
utue.personen.roh	Rigazio, Anna
utue.personen.roh	Lluch, Nuria
utue.personen.roh	Llorente, Nereida
utue.personen.roh	Diede, Scott J.
utue.personen.roh	Salvador, Hector
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	44	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE